Relations of blood inflammatory marker levels with cerebral microbleeds

Kaori Miwa1, Makiko Tanaka, Shuhei Okazaki

  • 1Department of Neurology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. miwa@osaka-njm.net

Stroke
|August 27, 2011
PubMed

Insights

Inflammation is linked to cerebral microbleeds (CMB). Higher levels of inflammatory markers like hsCRP, IL-6, and IL-18 were associated with the presence and location of CMB in elderly patients.

Area of Science:

  • Neurology
  • Vascular Biology
  • Immunology

Background:

  • Cerebral microbleeds (CMB) are markers of small vessel disease, common in the elderly.
  • The role of inflammation in CMB development is not fully understood.
  • Inflammatory processes are implicated in both large and small vessel diseases.

Purpose of the Study:

  • To investigate the relationship between inflammatory marker levels and the presence of CMB.
  • To determine if inflammation plays a role in the pathogenesis of CMB.

Main Methods:

  • Prospective enrollment of 431 patients without prior cerebrovascular disease.
  • Assessment of CMB presence and number using gradient-echo MRI.
  • Measurement of serum levels for high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and interleukin-18 (IL-18).

Main Results:

  • CMB were detected in 15% of patients (65 out of 431).
  • Patients with CMB showed higher levels of hsCRP, IL-6, and IL-18 compared to those without.
  • Elevated levels of these inflammatory markers were significantly associated with the presence of CMB, even after adjusting for cardiovascular risk factors.

Conclusions:

  • Increased levels of hsCRP, IL-6, and IL-18 are associated with CMB.
  • Inflammation appears to be involved in the development of both deep and lobar CMB.
  • These findings highlight the potential role of inflammatory pathways in small vessel disease affecting the brain.
Abstract

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...